Visible Light Photoredox Catalysis: Synthesis of Indazolo[2,3-a]quinolines from 2-(2-Nitrophenyl)-1,2,3,4-tetrahydroquinolines
Authors:
- 11 September 2013
- journal article
- letter
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 15 (18) , 4862-4865
Abstract
The synthesis of indazolo[2,3-a]quinoline derivatives in moderate to good yields from 2-(2-nitrophenyl)-1,2,3,4-tetrahydroquinolines via visible light photoredox catalysis is reported. The reaction involves a novel ruthenium-catalyzed intramolecular formation of the N–N bond of the indazole ring.Keywords
This publication has 70 references indexed in Scilit:
- Synthesis and Structure–Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) AntagonistsJournal of Medicinal Chemistry, 2013
- Recent Advances in the Chemistry of IndazolesEuropean Journal of Organic Chemistry, 2008
- Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)–Deficient Pancreatic Cancer CellsCancer Research, 2006
- The search for novel TRPV1-antagonists: From carboxamides to benzimidazoles and indazolonesBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agentsBioorganic & Medicinal Chemistry, 2006
- Pharmacological Properties of Indazole Derivatives: Recent DevelopmentsMini-Reviews in Medicinal Chemistry, 2005
- Indazole Estrogens: Highly Selective Ligands for the Estrogen Receptor βJournal of Medicinal Chemistry, 2005
- Synthesis and antiinflammatory activity of novel indazolonesArchives of Pharmacal Research, 2003
- The recent impact of solid-phase synthesis on medicinally relevant benzoannelated nitrogen heterocyclesBioorganic & Medicinal Chemistry, 2002
- Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infectionBioorganic & Medicinal Chemistry Letters, 2001